Regeneron Pharmaceuticals has selected Veeva Vault CRM for global use, expanding its strategic partnership with Veeva Systems. The life-sciences company plans to use AI-supported field customer engagement on the platform to generate commercial insights, identify hidden barriers to treatment acceptance, and help eligible patients gain access to its medicines. Regeneron’s Ryan Steinberger said the move to Vault CRM will give sales teams a more connected platform and faster access to information for decision-making. Veeva’s Matt Farrell said the expanded partnership supports Regeneron as it continues to bring important new medicines to people in need. Vault CRM’s Agentic Call Report is designed to turn each field interaction into a source of commercial evidence. Veeva serves more than 1,500 life-sciences customers and cautioned that actual results from its products and services could differ materially from current expectations.